Kilambi News
Friday, November 20, 2026

Life sciences also notable

Life Sciences Friday, November 20, 2026 - Updated Nov 20, 2026 07:13

Merck has partnered with Isomorphic Labs to develop oncology drug candidates, Chinese AI lab MegaRobo has raised nearly $200 million, Lilly has started work on its Pennsylvania obesity plant, and UK regulators opened consultations on gene therapy regulation and the Innovative Devices Access Pathway.

Why it matters: The Merck-Isomorphic deal extends the run of AI drug discovery partnerships into oncology, and MegaRobo's raise underlines the capital still flowing to Chinese laboratory automation.

Data as of Items published November 19, 2026 by STAT, Endpoints News and UK government publications; the Merck-Isomorphic partnership was carried by both STAT and Endpoints News, and the MegaRobo figure is Endpoints News' own headline figure.

Merck partners with Isomorphic Labs. Merck has partnered with Isomorphic Labs, the Alphabet-owned AI drug discovery company, to develop oncology drug candidates, STAT and Endpoints News reported. The deal extends the run of large pharma partnerships with AI discovery platforms into cancer.

MegaRobo raises nearly $200 million. Chinese AI laboratory automation company MegaRobo has raised nearly $200 million, Endpoints News reported, underlining the capital still flowing to Chinese robotics and laboratory AI even as US-China technology tensions widen.

Lilly breaks ground in Pennsylvania. Lilly has started work on its Pennsylvania obesity drug plant, Endpoints News reported, part of the company’s US manufacturing expansion for its obesity franchise.

UK device and gene therapy consultations. UK regulators published guidance on the Innovative Devices Access Pathway and opened a consultation on the regulation of gene therapy medicinal products, setting out the next steps in the post-Brexit device and advanced therapy rulebooks.

Sources

  1. Merck, Isomorphic Labs partner to develop oncology drug candidates - STAT - 2026-11-19
  2. Chinese AI lab MegaRobo raises nearly $200M; Isomorphic partners with Merck - Endpoints News - 2026-11-19
  3. Guidance: The Innovative Devices Access Pathway (IDAP) - UK Government (MHRA) - 2026-11-19